drugset / Trial / NCT03613545

Fecal Microbiota Transplantation for Irritable Bowel Syndrome

NCT03613545

Phase 2/3 Recruiting 120 enrolled Guangzhou First People's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. FMT has a higher cure rate than standard antibiotic treatment for recurrent Clostridium difficile infections,and shows promising results in Inflammatory bowel disease(IBD).However, few studies have evaluated whether FMT is effective to treat Irritable bowel syndrome(IBS).The investigators propose to determine the efficiency and safety of FMT in patients with Irritable bowel syndrome.

Timeline

Start
2018-08-10
Primary completion
2028-12-31
Completion
2030-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rifaximin Other / unclassified